The MarketReader Minute
💊 Moderna Falls Despite RSV Vaccine Approval, Gilead Drops on Downgrade, Amgen Rises on Positive Trial Results | Biotech Sector Insights
(IBB) has seen a price increase of 0.3% since Thursday. Significant contributors to this performance include Vertex Pharmaceuticals (VRTX), which reached an all-time high and experienced substantial gains over the past year.